These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16370076)
1. Access to AIDS medicine: ethical considerations. Swartz O Indian J Med Ethics; 2004; 1(3):75-6. PubMed ID: 16370076 [No Abstract] [Full Text] [Related]
2. Why life-saving drugs should be public goals. Kamtekar R Indian J Med Ethics; 2004; 1(3):77-8. PubMed ID: 16370077 [No Abstract] [Full Text] [Related]
3. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective. Viana JM Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298 [No Abstract] [Full Text] [Related]
4. An unequal activism for an unequal epidemic? Selemogo M Dev World Bioeth; 2005 May; 5(2):153-68. PubMed ID: 15842724 [TBL] [Abstract][Full Text] [Related]
5. The global impact of Indian generics on access to health. Ravinetto RM; Dorlo TP; Caudron JM; Prashanth NS Indian J Med Ethics; 2013; 10(2):118-20. PubMed ID: 23697493 [No Abstract] [Full Text] [Related]
6. Rights, patents, markets and the global AIDS pandemic. Gathii JT Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139 [No Abstract] [Full Text] [Related]
7. Access to medicines and the rhetoric of responsibility. Barry C; Raworth K Ethics Int Aff; 2002; 16(2):57-70. PubMed ID: 15709279 [No Abstract] [Full Text] [Related]
8. Your money or your life: a new variation on the Heinz Dilemma. Thompson RE Physician Exec; 2004; 30(1):58-61. PubMed ID: 14983708 [TBL] [Abstract][Full Text] [Related]
9. Gene donors' rights at risk. Nature; 1996 May; 381(6577):1. PubMed ID: 8609968 [No Abstract] [Full Text] [Related]
10. Access to essential drugs, human rights and global justice. Shalev C Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024 [No Abstract] [Full Text] [Related]
11. Ensuring new medicines reach those in most need. Burrone E; Perry G Lancet HIV; 2015 Sep; 2(9):e362-3. PubMed ID: 26423544 [No Abstract] [Full Text] [Related]
12. Facilitating access of AIDS drugs while maintaining strong patent protection. Ziker D Duke Law Technol Rev; 2001 Dec; ():E1. PubMed ID: 15709282 [TBL] [Abstract][Full Text] [Related]
13. Affordable access to essential medication in developing countries: conflicts between ethical and economic imperatives. Schüklenk U; Ashcroft RE J Med Philos; 2002 Apr; 27(2):179-95. PubMed ID: 11961696 [TBL] [Abstract][Full Text] [Related]
14. Priceless goods: how should life-saving drugs be priced? Maitland I Bus Ethics Q; 2002 Oct; 12(4):451-80. PubMed ID: 12708456 [TBL] [Abstract][Full Text] [Related]
15. Access to HIV drugs: are we changing the two world paradigm? Lazzarini Z Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297 [No Abstract] [Full Text] [Related]
16. US Senator calls for bill to increase access to HIV/AIDS medication. Hemsley A Pharm Pat Anal; 2012 Jul; 1(3):238-9. PubMed ID: 24386665 [No Abstract] [Full Text] [Related]
17. Access to antiretrovirals in South Africa. Reprod Health Matters; 2001 Nov; 9(18):180. PubMed ID: 11803902 [No Abstract] [Full Text] [Related]
18. Making tenofovir accessible in the brazilian public health system: patent conflicts and generic production. Veras J Dev World Bioeth; 2014 Aug; 14(2):92-100. PubMed ID: 24889312 [TBL] [Abstract][Full Text] [Related]
19. Will presumed consent make transplantation accessible, ethical and affordable in India? Nagral S Indian J Med Ethics; 2009; 6(3):155-6. PubMed ID: 19653593 [No Abstract] [Full Text] [Related]
20. Essential AIDS medications in India. Thomas J Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350 [No Abstract] [Full Text] [Related] [Next] [New Search]